14h30
Opening
Health Cluster Portugal
EIT Health Innostars
EIT Health Innostars
Voltar
14–28 Abril 2026
JoinHealth – Spring welcome webinars 2026
O ciclo JoinHealth Spring Webinar Series 2026 teve como temas centrais: financiamento público nacional, propriedade industrial na saúde digital e desenvolvimento de dispositivos médicos.
Sobre
O ciclo de webinars JoinHealth Spring Series 2026 decorreu no mês de abril de 2026, promovido no âmbito do DigiHealthPT – um Polo de Inovação Digital focado no setor da saúde.
- 14/04/2026 – PT2030 Funding & Complementary Tax Incentives
- 21/04/2026 – Protection of the Industrial Property in the Digital Health field
- 28/04/2026 – Medical Devices (Pre-)Clinical Development Strategy
Reveja os webinares aqui
Programa
14h35
PT2030 – Framework and Context
What PT2030 is and how it works.
Different programs and instruments available to companies.
Different programs and instruments available to companies.
The “Big 4” of PT2030
Overview of the four core support typologies.
How they align with the business life cycle.
How they align with the business life cycle.
Funding Instruments Overview
R&D (Research & Development).
Productive Innovation.
SME Qualification.
SME Internationalization.
Productive Innovation.
SME Qualification.
SME Internationalization.
Complementary Tax Incentives
Key tax incentives that can complement PT2030 funding.
Important rules and constraints on accumulation.
Important rules and constraints on accumulation.
Key Takeaways & Next Steps
How to identify the right instrument for your company.
Practical guidance on preparation and timing.
Speaker: Ana Henriques (Senior Project Manager, IPN)
Practical guidance on preparation and timing.
Speaker: Ana Henriques (Senior Project Manager, IPN)
15h20
Q&A Session
15h30
Closing remarks
Health Cluster Portugal
EIT Health Innostars
EIT Health Innostars
00h00
Opening
Health Cluster Portugal
EIT Health Innostars
EIT Health Innostars
14h20
Industrial Property applied to the digital health fields
Industrial Property: key concepts.
Patentability requirements.
Patents in Digital Health: key considerations and pitfalls.
Patentability requirements.
Patents in Digital Health: key considerations and pitfalls.
Intellectual Property Strategies for Digital Health Startups and SMEs
The relevance of intellectual property for attracting investment, partnerships, and scale-up.
Industrial property according to the solution’s development stage: relevance and strategic approaches.
Opportunities and challenges.
Speaker: Alexandra Mendes (Patent Examiner, INPI)
Industrial property according to the solution’s development stage: relevance and strategic approaches.
Opportunities and challenges.
Speaker: Alexandra Mendes (Patent Examiner, INPI)
15h35
Case study
How Industrial Property can contribute to a company’s success – the Perceive3D case
Alexandra Mendes (Patent Examiner, INPI)
Alexandra Mendes (Patent Examiner, INPI)
16h00
Closing remarks
Health Cluster Portugal
EIT Health Innostars
EIT Health Innostars
14h30
Opening
Health Cluster Portugal
EIT Health Innostars
EIT Health Innostars
14h35
Preclinical evidence behind the guidelines
What Preclinical Evidence Is Expected - and at What Stage.
Linking Preclinical Evidence to the General Safety and Performance Requirements (GSPR).
Usability Studies as Part of Preclinical Evidence.
Speaker: Ana Brito (Coordinator of the Medical Devices Regulatory Support Unit, IPN)
Linking Preclinical Evidence to the General Safety and Performance Requirements (GSPR).
Usability Studies as Part of Preclinical Evidence.
Speaker: Ana Brito (Coordinator of the Medical Devices Regulatory Support Unit, IPN)
15h00
Clinical Evaluation Strategy
Building a Risk‑Aligned Clinical Evaluation Strategy.
The Art of Literature: Building a Robust Clinical Evaluation Report (CER).
Integrating PMS, PMCF and Evidence Generation in a Clinical Evidence Lifecycle.
Speaker: Inês Urbano (Medical Devices Regulatory Affairs Consultant, IPN)
The Art of Literature: Building a Robust Clinical Evaluation Report (CER).
Integrating PMS, PMCF and Evidence Generation in a Clinical Evidence Lifecycle.
Speaker: Inês Urbano (Medical Devices Regulatory Affairs Consultant, IPN)
15h30
Early clinical validation
The Sweet Spot: When Early Validation Drives Real Progress.
ISO 14155 fundamentals for early feasibility and pilot studies.
Designing high‑quality early clinical studies: Endpoints, Methodology & Scalable Evidence.
Speaker: Maria Nascimento (Testing and Validation Sub-Unit Coordinator, IPN)
ISO 14155 fundamentals for early feasibility and pilot studies.
Designing high‑quality early clinical studies: Endpoints, Methodology & Scalable Evidence.
Speaker: Maria Nascimento (Testing and Validation Sub-Unit Coordinator, IPN)
16h00
Q&A Session
16h10
Closing
Health Cluster Portugal
EIT Health Innostars
EIT Health Innostars